Načítá se...
Hepatitis C Treatment Uptake among People who Inject Drugs in the Oral Direct-Acting Antiviral Era
BACKGROUND: Increased uptake of hepatitis C virus (HCV) treatment among people who inject drugs (PWID) will be critical to achieve HCV elimination goals. There are limited data on HCV treatment uptake among PWID recruited from community-based settings in the HCV direct-acting antiviral (DAA) era. ME...
Uloženo v:
| Vydáno v: | Liver Int |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7706292/ https://ncbi.nlm.nih.gov/pubmed/32770638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14634 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|